Medicare Enrolled

Dr. Melissa Wynn, MD

Infectious Disease · Savannah, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7120 HODGSON MEMORIAL DR, Savannah, GA 31406
9123524490
In practice since 2005 (21 years)
NPI: 1215934898 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wynn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wynn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wynn

Dr. Melissa Wynn is an infectious disease specialist in Savannah, GA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Wynn performed 5,115 Medicare services across 1,143 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wynn received a total of $8,985 from 28 pharmaceutical and/or device companies across 529 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wynn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice ▲ Top 10% volume in GA $8,985 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,115
Medicare services
Top 10% in GA for infectious disease
1,143
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~244 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
3,795 $60 $78
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
655 $62 $135
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
258 $131 $218
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
165 $86 $112
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
137 $76 $129
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
105 $56 $73
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,985
Total received (2018-2024)
Avg $1,284/year across 7 years
Top 18% in GA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
529
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,035 (89.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$950 (10.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,590
2023
$1,631
2022
$1,372
2021
$1,116
2020
$1,273
2019
$983
2018
$1,020

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ViiV Healthcare Company
$535
Astellas Pharma US Inc
$202
Gilead Sciences, Inc.
$157
Merck Sharp & Dohme LLC
$149
Cumberland Pharmaceuticals, Inc.
$138
Shionogi Inc
$129
ABBVIE INC.
$107
Paratek Pharmaceuticals, Inc.
$74
Melinta Therapeutics, LLC
$60
Insmed, Inc.
$37
Top 3 companies account for 56.3% of 2024 payments
All-time payments by company (2018-2024) ›
ViiV Healthcare Company
$1,708
Gilead Sciences, Inc.
$1,123
Astellas Pharma US Inc
$958
Insmed, Inc.
$737
Merck Sharp & Dohme Corporation
$691
Merck Sharp & Dohme LLC
$426
Janssen Biotech, Inc.
$395
Shionogi Inc
$385
ABBVIE INC.
$378
Theratechnologies Inc.
$336
Allergan Inc.
$289
AbbVie Inc.
$274
Melinta Therapeutics, LLC
$219
Cumberland Pharmaceuticals, Inc.
$207
Paratek Pharmaceuticals, Inc.
$202
Allergan, Inc.
$147
La Jolla Pharmaceutical Company
$122
Ferring Pharmaceuticals Inc.
$122
TETRAPHASE PHARMACEUTICALS, INC.
$64
Nabriva Therapeutics, plc
$36
EMD Serono, Inc.
$33
Janssen Pharmaceuticals, Inc
$28
Napo Pharmaceuticals Inc
$27
SCYNEXIS, Inc.
$20
Janssen Scientific Affairs, LLC
$18
RedHill Biopharma Inc.
$15
Theravance Biopharma, Inc.
$13
VYERA PHARMACEUTICALS, LLC
$11
Top 3 companies account for 42.2% of all-time payments
Associated products mentioned in payments ›
APRETUDE · AVYCAZ · Aemcolo · Arikayce · CABENUVA · CRESEMBA · Cresemba · DALVANCE · DIFICID · DOVATO · Daraprim · Descovy · EGRIFTA · Fetroja · ISENTRESS · JULUCA · Kimyrsa · MAVYRET · Mytesi · NOXAFIL · NUZYRA · Orbactiv · PIFELTRO · PREZCOBIX · REBYOTA · RUKOBIA · Rezzayo · SEROSTIM · SYMTUZA · Sivextro · Symtuza · TEFLARO · TRIUMEQ · TROGARZO · Truvada · VIBATIV · Vabomere · Veklury · Vibativ · XERAVA · Xenleta · Xerava · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an infectious disease specialist in Savannah?
Compare infectious diseases in the Savannah area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
7
Per 100K population
2.3
County median income
$69,575
Nearest hospital
COASTAL HARBOR TREATMENT CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wynn is a clinical cardiology specialist, with above-average Medicare volume (top 10% in GA), with low-engagement industry engagement in the top 18% of GA peers, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wynn experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Wynn performed 3,795 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wynn receive payments from pharmaceutical companies?
Yes. Dr. Wynn received a total of $8,985 from 28 companies across 529 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wynn's costs compare to other infectious diseases in Savannah?
Dr. Wynn's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wynn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →